Antibodies are essential molecules for diagnosis and treatment of diseases caused by
pathogens and their toxins. Antibodies were integrated in our medical repertoire against …

Safe and effective paediatric formulations of the most promising antiretroviral drugs are
crucial to advance the treatment and prevention of HIV in neonates, infants, children, and …

Increasingly, antibodies are being used to treat and prevent viral infections. In the context of
HIV, efficacy is primarily attributed to dose-dependent neutralization potency and to a lesser …

Introduction The last 12 years have seen remarkable progress in the isolation and
characterization of at least five different epitope classes of HIV‐specific broadly neutralizing …

Background Effective, long-acting prevention approaches are needed to reduce human
immunodeficiency virus (HIV) incidence. We evaluated the safety and pharmacokinetics of …

Viral diseases represent a major public health concerns and ever-present risks for
developing into future pandemics. Antiviral antibody therapeutics, either alone or in …

HIV-1 bNAbs can enhance adaptive host immune responses in PLWH. The challenge now
is to exploit these immunomodulatory properties to design optimized therapeutic …

Early initiation of antiretroviral therapy (ART) significantly improves clinical outcomes and
reduces mortality of infants/children living with HIV. However, the ability of infected cells to …

ABSTRACT HIV-1 has eluded vaccine therapy for the past 40 years. The virus mutates
rapidly and is protected by a shifting glycan shield of mannose sugars, which has hindered …

HIV cure: an acceptability scientific agenda : Current Opinion in HIV and AIDS HIV cure: an
acceptability scientific agenda : Current Opinion in HIV and AIDS Log in or Register Subscribe to …